Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

MIXED(28)
DRUG(8)
BIOLOGICAL(2)
PROCEDURE(1)
laboratory biomarker analysis
4 trials
phase_1phase_1_2
city-of-hope-medical-center
Biospecimen Collection
2 trials
phase_1
city-of-hope-medical-center
pharmacological study
2 trials
phase_1
city-of-hope-medical-center
Pembrolizumab
2 trials
phase_1phase_2
city-of-hope-medical-center
Computed Tomography
2 trials
phase_1
city-of-hope-medical-center
Magnetic Resonance Imaging
2 trials
phase_1
city-of-hope-medical-center
cyclophosphamide
1 trial
phase_2
city-of-hope-medical-center
celecoxib
1 trial
phase_2
city-of-hope-medical-center

+23 more interventions

31 unique interventions4 categories

Analytics

Trial Phases

Phase 17
Phase 23

Trial Status

Completed2
Recruiting1
Other6

Role Distribution

Principal Investigator9
PI Rate100%

Activity Timeline

Clinical Trials (9)

NCT06454383Phase 1Recruiting
Gemcitabine and Leflunomide in Patients With Advanced Unresectable Pancreatic Cancer
Advanced Pancreatic AdenocarcinomaStage III Pancreatic Cancer AJCC v8Stage IV Pancreatic Cancer AJCC v8+1 more
PrincipalinvestigatorStart date: 2024-06-10
NCT04887805Phase 2Active Not Recruiting
Lenvatinib and Pembrolizumab Maintenance Therapy for the Treatment of Patients of Advanced Unresectable Pancreatic Cancer
Advanced Pancreatic Ductal AdenocarcinomaStage II Pancreatic Cancer AJCC v8Stage IIA Pancreatic Cancer AJCC v8+4 more
PrincipalinvestigatorStart date: 2021-07-21
NCT02112565Phase 1Active Not Recruiting
RNR Inhibitor COH29 in Treating Patients With Solid Tumors That Are Refractory to Standard Therapy or For Which No Standard Therapy Exists
Unspecified Adult Solid Tumor, Protocol Specific
PrincipalinvestigatorStart date: 2017-01-09
NCT02336087Phase 1Active Not Recruiting
Gemcitabine Hydrochloride, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Metformin Hydrochloride, and a Standardized Dietary Supplement in Treating Patients With Pancreatic Cancer That Cannot be Removed by Surgery
Pancreatic AdenocarcinomaStage III Pancreatic Cancer AJCC v6 and v7Stage IV Pancreatic Cancer AJCC v6 and v7+1 more
PrincipalinvestigatorStart date: 2016-03-17
NCT02432963Phase 1Active Not Recruiting
Vaccine Therapy and Pembrolizumab in Treating Patients With Solid Tumors That Have Failed Prior Therapy
Adult Solid NeoplasmBladder CarcinomaColon Carcinoma+14 more
PrincipalinvestigatorStart date: 2015-12-28
NCT00538031Phase 2Completed
Cyclophosphamide With or Without Celecoxib in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
Fallopian Tube CancerPeritoneal Cavity CancerRecurrent Ovarian Epithelial Cancer
PrincipalinvestigatorStart date: 2003-12-22
NCT01231399Phase 1/2Completed
Everolimus and Combination Chemotherapy in Treating Patients With Metastatic Stomach or Esophageal Cancer
Adenocarcinoma of the EsophagusAdenocarcinoma of the Gastroesophageal JunctionDiffuse Adenocarcinoma of the Stomach+6 more
Principalinvestigator
NCT01741597Phase 1Withdrawn
Dynamic Contrast Enhanced MRI in Patients With Advanced Breast or Pancreatic Cancer With Metastases to the Liver or Lung
Acinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasLiver Metastases+5 more
Principalinvestigator
NCT06626256Phase 1Withdrawn
STIL101 for Injection for the Treatment of Locally Advanced, Metastatic or Unresectable Pancreatic Cancer, Colorectal Cancer, Renal Cell Cancer, Cervical Cancer and Melanoma
Locally Advanced Cervical CarcinomaLocally Advanced Colorectal CarcinomaLocally Advanced Malignant Solid Neoplasm+24 more
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Rahul Aggarwal, MD

University of California, San Francisco

Related
22 trials

Shared therapeutic areas:

Metastatic Malignant Solid NeoplasmLocally Advanced Malignant Solid NeoplasmLocally Advanced Melanoma+6 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score4%

Stanislaw R. Burzynski, MD, PhD

Burzynski Research Institute

Related
62 trials

Shared therapeutic areas:

Stage IV Breast CancerRecurrent Breast CancerSarcoma+1 more
Similarity Score2%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

MelanomaMetastatic MelanomaCarcinoma, Non-Small-Cell Lung

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score1%

Ajay Goel, PhD

City of Hope Medical Center

Related
24 trials

Shared therapeutic areas:

Carcinoma, HepatocellularPancreatic AdenocarcinomaPancreatic Carcinoma

Worked with same sponsors:

City of Hope Medical Center
Similarity Score1%

Zhenfeng Zhang, MD, PhD

Second Affiliated Hospital of Guangzhou Medical University

Related
21 trials

Shared therapeutic areas:

Carcinoma, HepatocellularCarcinoma, Non-Small-Cell LungSarcoma
Similarity Score1%

Jeong Min Lee, MD

Seoul National University Hospital

Related
34 trials

Shared therapeutic areas:

Carcinoma, HepatocellularLiver Metastases
Similarity Score1%

Zhaohui Zhu, MD

Peking Union Medical College Hospital

Related
19 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell LungCarcinoma, Renal Cell
Similarity Score1%

Saleh K Saleh, MD

Minia University

Related
23 trials

Shared therapeutic areas:

Carcinoma, HepatocellularLiver Metastases
Similarity Score1%

Aminah Jatoi, MD

Mayo Clinic

Related
29 trials

Shared therapeutic areas:

Unspecified Adult Solid Tumor, Protocol SpecificAdenocarcinoma of the Gastroesophageal Junction

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score1%

E-mail: ClinicalTrials@ ImClone.com

Eli Lilly and Company

Related
22 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell LungMelanoma
Similarity Score1%

Publications (0)

No publications found for this investigator.

Clinical Trials (9)

Showing 9 of 9 trials

NCT06454383Phase 1PrincipalInvestigator

Gemcitabine and Leflunomide in Patients With Advanced Unresectable Pancreatic Cancer

Advanced Pancreatic AdenocarcinomaStage III Pancreatic Cancer AJCC v8Stage IV Pancreatic Cancer AJCC v8+1 more
Recruiting
NCT04887805Phase 2PrincipalInvestigator

Lenvatinib and Pembrolizumab Maintenance Therapy for the Treatment of Patients of Advanced Unresectable Pancreatic Cancer

Advanced Pancreatic Ductal AdenocarcinomaStage II Pancreatic Cancer AJCC v8Stage IIA Pancreatic Cancer AJCC v8+4 more
Active Not Recruiting
NCT02112565Phase 1PrincipalInvestigator

RNR Inhibitor COH29 in Treating Patients With Solid Tumors That Are Refractory to Standard Therapy or For Which No Standard Therapy Exists

Unspecified Adult Solid Tumor, Protocol Specific
Active Not Recruiting
NCT02336087Phase 1PrincipalInvestigator

Gemcitabine Hydrochloride, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Metformin Hydrochloride, and a Standardized Dietary Supplement in Treating Patients With Pancreatic Cancer That Cannot be Removed by Surgery

Pancreatic AdenocarcinomaStage III Pancreatic Cancer AJCC v6 and v7Stage IV Pancreatic Cancer AJCC v6 and v7+1 more
Active Not Recruiting
NCT02432963Phase 1PrincipalInvestigator

Vaccine Therapy and Pembrolizumab in Treating Patients With Solid Tumors That Have Failed Prior Therapy

Adult Solid NeoplasmBladder CarcinomaColon Carcinoma+14 more
Active Not Recruiting
NCT00538031Phase 2PrincipalInvestigator

Cyclophosphamide With or Without Celecoxib in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

Fallopian Tube CancerPeritoneal Cavity CancerRecurrent Ovarian Epithelial Cancer
Completed
NCT01231399Phase 1/2PrincipalInvestigator

Everolimus and Combination Chemotherapy in Treating Patients With Metastatic Stomach or Esophageal Cancer

Adenocarcinoma of the EsophagusAdenocarcinoma of the Gastroesophageal JunctionDiffuse Adenocarcinoma of the Stomach+6 more
Completed
NCT01741597Phase 1PrincipalInvestigator

Dynamic Contrast Enhanced MRI in Patients With Advanced Breast or Pancreatic Cancer With Metastases to the Liver or Lung

Acinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasLiver Metastases+5 more
Withdrawn
NCT06626256Phase 1PrincipalInvestigator

STIL101 for Injection for the Treatment of Locally Advanced, Metastatic or Unresectable Pancreatic Cancer, Colorectal Cancer, Renal Cell Cancer, Cervical Cancer and Melanoma

Locally Advanced Cervical CarcinomaLocally Advanced Colorectal CarcinomaLocally Advanced Malignant Solid Neoplasm+24 more
Withdrawn

All 9 trials loaded